Vaxxilon
Vaxxilon AG is focused on the discovery and development of innovative synthetic carbohydrate vaccines.
Launch date
Company register number CH-280.3.019.032-0
Reinach Canton of Basel-Landschaft (HQ)
Financials
Estimates*
EUR | 2015 | 2016 | 2017 | 2018 |
---|---|---|---|---|
Revenues | 4.6m | 4.7m | 4.3m | 4.4m |
% growth | - | 1 % | (8 %) | 4 % |
Source: Dealroom estimates
Date | Investors | Amount | Round |
---|---|---|---|
N/A | Spinout | ||
$1.4m | Grant | ||
N/A | Acquisition | ||
Total Funding | CAD1.9m |
Related Content
Recent News about Vaxxilon
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.